-transparent.png){kind=logo}
The pharmacokinetics of ceforanide were evaluated in 11 patients with end stage renal disease (creatinine clearance less than 5 ml/min). A single intravenous dose of 750 mg/m2 produced peak plasma concentrations of 123 +/- 29 microgram/ml. The plasma half-life (T 1/2) of the drug was 19.1 +/- 2.5 h. A 5.5 h hemodialysis session removed 53% of the drug and reduced the T 1/2 to 5 +/- 0.7 h. Plasma concentrations greater than 10 microgram/m2 were maintained without adverse effects with a 1.5-g/m2 dose administered three times a week for 2 weeks.
Related Publications
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
March 1995,
American journal of kidney diseases : the official journal of the National Kidney Foundation,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
September 1978,
Antimicrobial agents and chemotherapy,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
December 2017,
Annals of vascular diseases,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
January 1988,
Chemotherapy,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
December 2006,
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
October 2006,
Hemodialysis international. International Symposium on Home Hemodialysis,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
May 1999,
Pharmacotherapy,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
September 2000,
Clinical pharmacology and therapeutics,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
October 2019,
Journal of clinical pharmacology,
J R Hess, and
S J Berman, and
W H Boughton, and
J G Sugihara, and
J E Musgrave, and
E G Wong, and
A M Siemsen
November 2022,
Antimicrobial agents and chemotherapy,
